A prototype online 3D dose verification tool using portal imaging has been developed and successfully tested for two different kinds of gross delivery errors. Thus, online 3D dose verification has been technologically achieved.
New physics interactions can affect the strength and structure of the tbW vertex. We investigate the magnitudes and phases of "anomalous" contributions to this vertex in a two-Higgs doublet and the minimal supersymmetric extension of the standard model, and in a top-color assisted technicolor (TC2) model. While the magnitudes of the anomalous couplings remain below 1 percent in the first two models, TC2 interactions can reduce the left-chiral coupling f L by several percent.
We analyze and compute, within a number of standard model (SM) extensions, the cross sections σ A→V V ′ for the production of a heavy neutral pseudoscalar Higgs boson/spinzero resonance at the LHC and its subsequent decays into electroweak gauge bosons. For comparison we calculate also the corresponding cross sections for a heavy scalar. The SM extensions we consider include a type-II two-Higgs doublet model (2HDM), a 2HDM with 4 chiral fermion generations, the minimal supersymmetric extension of the SM (MSSM), and top-color assisted technicolour models. Presently available phenomenological constraints on the parameters of these models are taken into account. We find that, with the exception of the MSSM, these models permit the LHC cross sections σ A→V V ′ to be of observable size. That is, a pseudoscalar resonance may be observable, if it exists, at the LHC in its decays into electroweak gauge bosons, in particular in W W and γγ final states.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.